Literature DB >> 16394135

"Promoter array" studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells.

Yipeng Wang1, Jun Hayakawa, Fred Long, Qiuju Yu, Ann H Cho, Gaelle Rondeau, John Welsh, Shalu Mittal, Ian De Belle, Eileen Adamson, Michael McClelland, Dan Mercola.   

Abstract

DNA microarrays of promoter sequences have been developed in order to identify the profile of genes bound and activated by DNA regulatory proteins such as the transcription factors c-Jun and ATF2 as well as DNA-modifying methylases. The arrays contain 3083 unique human promoter sequences from +500 to -1000 nts from the transcription start site. Cisplatin-induced DNA damage rapidly leads to specific activation of the Jun kinase pathway leading to increased phosphorylation of c-Jun and ATF2-DNA complexes at hundreds of sites within 3 hours. Using three statistical criteria, approximately 269 most commonly phosphorylated c-Jun/ATF2-DNA complexes were identified and representative cases were verified by qPCR measurement of ChIP-captured DNA. Expression was correlated at the mRNA and protein levels. The largest functional cohort was 24 genes of known DNA repair function, most of which exhibited increased protein expression indicated coordinate gene regulation. In addition, cell lines of prostate cancer exhibit stable methylation or copy number changes that reflect the alterations of the corresponding primary tumors. 504 (18.5%) promoters showed differential hybridization between immortalized control prostate epithelial and cancer cell lines. Among candidate hypermethylated genes in cancer-derived lines, eight had previously been observed in prostate cancer, and 13 were previously determined methylation targets in other cancers. The vast majority of genes that appear to be both differentially methylated and differentially regulated between prostate epithelial and cancer cell lines are novel methylation targets, including PAK6, RAD50, TLX3, PIR51, MAP2K5, INSR, FBN1, GG2-1, representing a rich new source of candidate genes to study the role of DNA methylation in prostate tumors. Earlier studies using prototype promoter arrays examine approximately 7% of the proximal regulatory sequences while the current gene regulatory events surveyed here occur on a large scale and may rapidly effect the coordinated expression of a large number of genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16394135     DOI: 10.1196/annals.1359.024

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Layered peptide array for multiplex immunohistochemistry.

Authors:  Gallya Gannot; Michael A Tangrea; Heidi S Erickson; Peter A Pinto; Stephen M Hewitt; Rodrigo F Chuaqui; John W Gillespie; Michael R Emmert-Buck
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

2.  Detection of genomic DNA methylation with denaturing high performance liquid chromatography.

Authors:  Romaica A Omaruddin; M Ahmad Chaudhry
Journal:  Hum Cell       Date:  2010-05       Impact factor: 4.174

3.  Evaluating oligonucleotide properties for DNA microarray probe design.

Authors:  Xiao-Qin Xia; Zhenyu Jia; Steffen Porwollik; Fred Long; Claudia Hoemme; Kai Ye; Carsten Müller-Tidow; Michael McClelland; Yipeng Wang
Journal:  Nucleic Acids Res       Date:  2010-03-17       Impact factor: 16.971

4.  Epigenomics in cancer management.

Authors:  Fabricio F Costa
Journal:  Cancer Manag Res       Date:  2010-10-27       Impact factor: 3.989

5.  DNA methylation intratumor heterogeneity in localized lung adenocarcinomas.

Authors:  Kelly Quek; Jun Li; Marcos Estecio; Jiexin Zhang; Junya Fujimoto; Emily Roarty; Latasha Little; Chi-Wan Chow; Xingzhi Song; Carmen Behrens; Taiping Chen; William N William; Stephen Swisher; John Heymach; Ignacio Wistuba; Jianhua Zhang; Andrew Futreal; Jianjun Zhang
Journal:  Oncotarget       Date:  2017-03-28

6.  Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip.

Authors:  Shilpi Arora; Yipeng Wang; Zhenyu Jia; Saynur Vardar-Sengul; Ayla Munawar; Kutbuddin S Doctor; Michael Birrer; Michael McClelland; Eileen Adamson; Dan Mercola
Journal:  Genome Biol       Date:  2008-11-25       Impact factor: 13.583

7.  Exome-based Variant Detection in Core Promoters.

Authors:  Yeong C Kim; Jian Cui; Jiangtao Luo; Fengxia Xiao; Bradley Downs; San Ming Wang
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

Review 8.  Tumor Necrosis Factor-α Induced Protein 8: Pathophysiology, Clinical Significance, and Regulatory Mechanism.

Authors:  Lei Zhang; Ran Liu; Ying-Yi Luan; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2018-03-10       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.